- Home
- WRN vs ZYXI Comparison
WRN vs ZYXI Comparison
Compare WRN & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRN
- ZYXI
- Stock Information
- Founded
- WRN 2006
- ZYXI 1996
- Country
- WRN Canada
- ZYXI United States
- Employees
- WRN N/A
- ZYXI N/A
- Industry
- WRN Metal Mining
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WRN Basic Materials
- ZYXI Health Care
- Exchange
- WRN Nasdaq
- ZYXI Nasdaq
- Market Cap
- WRN 237.4M
- ZYXI 248.4M
- IPO Year
- WRN N/A
- ZYXI N/A
- Fundamental
- Price
- WRN $1.14
- ZYXI $8.26
- Analyst Decision
- WRN Strong Buy
- ZYXI Strong Buy
- Analyst Count
- WRN 1
- ZYXI 2
- Target Price
- WRN $4.25
- ZYXI $14.00
- AVG Volume (30 Days)
- WRN 461.7K
- ZYXI 98.8K
- Earning Date
- WRN 11-07-2024
- ZYXI 10-24-2024
- Dividend Yield
- WRN N/A
- ZYXI N/A
- EPS Growth
- WRN N/A
- ZYXI N/A
- EPS
- WRN N/A
- ZYXI 0.15
- Revenue
- WRN N/A
- ZYXI $193,665,000.00
- Revenue This Year
- WRN N/A
- ZYXI $10.70
- Revenue Next Year
- WRN N/A
- ZYXI $19.78
- P/E Ratio
- WRN N/A
- ZYXI $55.93
- Revenue Growth
- WRN N/A
- ZYXI 4.21
- 52 Week Low
- WRN $0.95
- ZYXI $7.15
- 52 Week High
- WRN $1.66
- ZYXI $13.77
- Technical
- Relative Strength Index (RSI)
- WRN 45.00
- ZYXI 49.49
- Support Level
- WRN $1.11
- ZYXI $7.70
- Resistance Level
- WRN $1.16
- ZYXI $9.33
- Average True Range (ATR)
- WRN 0.06
- ZYXI 0.37
- MACD
- WRN -0.00
- ZYXI -0.08
- Stochastic Oscillator
- WRN 23.91
- ZYXI 34.36
About WRN Western Copper and Gold Corporation
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.